Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FP8SV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,843
Award facts
- Contract value 100% obligated
- $27,842.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,842.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML (risankizumab), a biologic medication used to treat inflammatory conditions such as plaque psoriasis and Crohn's disease. This non-set-aside contract was competitively awarded and is scheduled for completion by January 21, 2026. The awardee will perform work at its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. AmerisourceBergen's status as a critical vendor in the Defense Health Agency supply chain reflects its established capability to meet federal procurement requirements for specialty pharmaceuticals across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FP8SV?
SPE2DR26FP8SV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FP8SV worth?
The government has obligated $27,843 on SPE2DR26FP8SV.
Is contract SPE2DR26FP8SV an order under another contract?
Yes. SPE2DR26FP8SV is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8SV competed?
The extent of competition for SPE2DR26FP8SV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award